Carson Wealth (CWM LLC)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $51.3M | Buy |
66,400
+5,831
| +10% | +$4.46M | 0.13% | 152 |
|
|
2025
Q4 | $46.8M | Buy |
60,569
+7,163
| +13% | +$4.86M | 0.13% | 154 |
|
|
2025
Q3 | $30M | Buy |
53,406
+17,900
| +50% | +$10.1M | 0.09% | 190 |
|
|
2025
Q2 | $18.6M | Buy |
35,506
+31,425
| +770% | +$17.5M | 0.07% | 251 |
|
|
2025
Q1 | $2.59M | Buy |
4,081
+2,007
| +97% | +$1.38M | 0.01% | 745 |
|
|
2024
Q4 | $1.48M | Sell |
2,074
-198
| -9% | -$166K | 0.01% | 906 |
|
|
2024
Q3 | $2.39M | Buy |
2,272
+25
| +1% | +$27.8K | 0.01% | 646 |
|
|
2024
Q2 | $2.36M | Buy |
2,247
+49
| +2% | +$47.5K | 0.01% | 600 |
|
|
2024
Q1 | $2.12M | Sell |
2,198
-240
| -10% | -$228K | 0.01% | 606 |
|
|
2023
Q4 | $2.14M | Sell |
2,438
-256
| -10% | -$211K | 0.01% | 565 |
|
|
2023
Q3 | $2.22M | Buy |
2,694
+129
| +5% | +$101K | 0.01% | 522 |
|
|
2023
Q2 | $1.84M | Sell |
2,565
-115
| -4% | -$88.7K | 0.01% | 537 |
|
|
2023
Q1 | $2.2M | Buy |
2,680
+9
| +0.3% | +$6.79K | 0.01% | 461 |
|
|
2022
Q4 | $1.93M | Buy |
2,671
+18
| +0.7% | +$13.3K | 0.01% | 458 |
|
|
2022
Q3 | $1.83M | Buy |
2,653
+194
| +8% | +$122K | 0.01% | 433 |
|
|
2022
Q2 | $1.45M | Sell |
2,459
-248
| -9% | -$161K | 0.01% | 464 |
|
|
2022
Q1 | $1.89M | Buy |
2,707
+6
| +0.2% | +$3.8K | 0.01% | 414 |
|
|
2021
Q4 | $1.71M | Buy |
+2,701
| New | +$1.66M | 0.01% | 469 |
|
|
2021
Q2 | $2.32M | Hold |
4,146
| – | – | 0.02% | 389 |
|
|
2021
Q1 | $2.32M | Hold |
4,146
| – | – | 0.02% | 389 |
|
|
2020
Q4 | $2.32M | Hold |
4,146
| – | – | 0.02% | 389 |
|
|
2020
Q3 | $2.32M | Hold |
4,146
| – | – | 0.02% | 389 |
|
|
2020
Q2 | $2.32M | Hold |
4,146
| – | – | 0.02% | 389 |
|
|
2020
Q1 | $2.32M | Hold |
4,146
| – | – | 0.02% | 389 |
|
|
2019
Q4 | $2.32M | Hold |
4,146
| – | – | 0.02% | 389 |
|
|
2019
Q3 | $2.32M | Hold |
4,146
| – | – | 0.02% | 389 |
|
|
2019
Q2 | $2.32M | Hold |
4,146
| – | – | 0.02% | 389 |
|
|
2019
Q1 | $2.32M | Buy |
4,146
+4,117
| +14,197% | +$1.7M | 0.02% | 389 |
|
|
2018
Q4 | $11K | Buy |
29
+18
| +164% | +$6.59K | ﹤0.01% | 1311 |
|
|
2018
Q3 | $4K | Sell |
11
-13
| -54% | -$4.95K | ﹤0.01% | 1410 |
|
|
2018
Q2 | $8K | Sell |
24
-24
| -50% | -$7.51K | ﹤0.01% | 1079 |
|
|
2018
Q1 | $17K | Buy |
48
+30
| +167% | +$10.4K | ﹤0.01% | 739 |
|
|
2017
Q4 | $7K | Sell |
18
-15
| -45% | -$6.08K | ﹤0.01% | 993 |
|
|
2017
Q3 | $15K | Buy |
33
+28
| +560% | +$13.3K | ﹤0.01% | 786 |
|
|
2017
Q2 | $2K | Buy |
+5
| New | +$2.19K | ﹤0.01% | 1028 |
|
|
2017
Q1 | – | Sell |
-17
| Closed | -$6K | – | 1293 |
|
|
2016
Q4 | $6K | Buy |
+17
| New | +$6.46K | ﹤0.01% | 825 |
|
|
2015
Q4 | – | Sell |
-28
| Closed | -$13K | – | 745 |
|
|
2015
Q3 | $13K | Buy |
+28
| New | +$15K | ﹤0.01% | 421 |
|
Other funds holding REGN
Carson Wealth (CWM LLC)'s REGN Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Regeneron Pharmaceuticals (REGN) stake by 9.6% in Q1 2026, buying an estimated $4.46M and bringing the position to 66,400 shares worth $51.3M. The position accounts for 0.13% of the portfolio, ranked #152.
Carson Wealth (CWM LLC) first reported a position in REGN in Q3 2015 and has held it in 37 quarters since. 1,400 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Carson Wealth (CWM LLC) held 66,400 shares of Regeneron Pharmaceuticals worth $51.3M as of Q1 2026.
- Carson Wealth (CWM LLC) bought 5,831 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $4.46M.
- Regeneron Pharmaceuticals made up 0.13% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #152 holding.
- Carson Wealth (CWM LLC) first reported a position in Regeneron Pharmaceuticals in Q3 2015 and has held it in 37 quarters since.
- 1,400 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.